Summary

for people ages 18 years and up (full criteria)
at La Jolla, California and other locations
study started
estimated completion:

Description

Summary

The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in subjects with progressive supranuclear palsy (PSP).

Keywords

Progressive Supranuclear Palsy (PSP) Supranuclear Palsy, Progressive ABBV-8E12

Eligibility

You can join if…

Open to people ages 18 years and up

  • Subject completed Study C2N-8E12-WW-104 (NCT02494024)
  • Subject was not eligible to enroll in Study M15-562 (NCT02985879)

You CAN'T join if...

  • Subject weighs less than 35 kg at screening
  • Subject has any contraindication or inability to tolerate brain MRI
  • Subject has any significant change in his/her medical condition that could interfere with the subject's participation in the study, could place the subject at increased risk, or could confound interpretation of study results

Locations

  • University of California, San Diego /ID# 170113
    La Jolla California 92093 United States
  • Kerwin Research Center /ID# 170112
    Dallas Texas 75218 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
AbbVie
ID
NCT03413319
Phase
Phase 1
Study Type
Interventional
Last Updated